| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| teplizumab | t-cell surface glycoprotein cd3 epsilon chain | biotech | NA | drugbank , DGIDB | Diabetes Mellitus Insulin-Dependent[MeSHID:D003922] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] melanoma[MeSHID:D008545] |
6.37 | investigational | antagonist |
| teplizumab | t-cell surface glycoprotein cd3 gamma | NA | Clinical trial target | TTD , DGIDB | Diabetes Mellitus Insulin-Dependent[MeSHID:D003922] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] melanoma[MeSHID:D008545] |
2.45 | phase 3 | unknown |
| click here to return to the previous page | ||||||||